Upon referral, all patients underwent thorough history and physical examination. Following this, a complete laboratory evaluation was ordered as subsequently discussed. Of the 37 patients, 21 were females (56.7%) and 16 were males (43.2%), a female-to-male ratio of 1.3:1. Twenty-six of the patients (70.9%) had arterial thrombosis and 11 patients (29.7%) had venous thrombosis. Six of the patients with arterial thrombosis (16.2%) had bilateral disease and two of the patients with venous thrombosis (0.54%) had bilateral disease. The mean age of the population was 46.7 years (17-79; SD, 18.9 years). The mean female age was 39.7 years (range, 17-79 years) and for males was 56.3 years (range, 17-79 years). This patient demographic data are summarized in Table 1 
RESULTS

Laboratory Findings
Nineteen patients (51.3%) had antiphospholipid syndrome; these will subsequently be discussed, seven patients (18.9%) had sticky platelet syndrome, two patients (5.4%) had factor V Leiden mutation, two patients had MTHFR C677T mutation, and one patient (2.7%) had PAI-I elevation. Six patients (16.2%) had no hemostasis defect by the above panel. Thus of the patients referred a thrombophilic condition was found in 31 of 37 patients (83.7%). The prothrombotic defects found are summarized in Table 2 . The patients with antiphospholipid syndrome deserve special comment because some, such as those with transient ischemic attacks and stroke (1) and those experiencing recurrent miscarriage, (2, 3) , show discordance between harboring the "common" antiphospholipid antibodies (anticardiolipin antibodies, IgG, IgA, and IgM or lupus anticoagulant) and harbored only one of the "subgroup antiphospholipid antibodies (antiphosphatidylserine, antiphosphatidylethanolamine, antiphosphatidic acid, antiphosphatidylcholine, antiphosphatidylglycerol, antiphosphatidylinositol, and anti-Annexin-V antibodies). In this series of patients, of the 19 with antiphospholipid syndrome, nine had anticardiolipin antibodies and one had a lupus anticoagulant (no anticardiolipin antibody). The one patient with a LA also had an IgG anticardiolipin antibody. Of those with anticardiolipin antibodies, 55% (five of nine) had IgG idiotype, 22% (two of nine) had IgG + IgM ACLAs. Thirty-three percent (three of nine) had IgG + IgA + IgM idiotypes, 11% (one of nine) had only IgM idiotype, and 22% (two of nine) had IgA idiotype only. Thus ten of 19 patients (52.6%) had a "common" antiphospholipid antibody, nine with anticardiolipin antibody and one with LA. The other nine patients with antiphospholipid syndrome (47.3%) had only a "subgroup" antiphospholipid antibody and absence of the "common" anticardiolipin antibodies (ACLA or LA). Of those 
DISCUSSION
Retinal vascular thrombosis is a common clinical problem, causing significant morbidity and impacting quality of life in millions of Americans. Many of these episodes remain unexplained in the ophthalmology community. The causes associated with retinal venous thrombosis and routinely assessed by the ophthalmologist include impaired venous blood flow behind the lamina cribrosa, turbulence of flow behind the lamina cribrosa (4, 5) , systemic hypertension (6), diabetes mellitus (6) , open-angle glaucoma (6) . in- 
